Assessment of Lung Cancer Risk Among Smokers for Whom Annual Screening Is Not Recommended.

Importance The US Preventive Services Task Force does not recommend annual lung cancer screening with low-dose computed tomography (LDCT) for adults aged 50 to 80 years who are former smokers with 20 or more pack-years of smoking who quit 15 or more years ago or current smokers with less than 20 pack-years of smoking. Objective To determine the risk of lung cancer in older smokers for whom LDCT screening is not recommended. Design, Settings, and Participants This cohort study used the Cardiovascular Health Study (CHS) data sets obtained from the National Heart, Lung and Blood Institute, which also sponsored the study. The CHS enrolled 5888 community-dwelling individuals aged 65 years and older in the US from June 1989 to June 1993 and collected extensive baseline data on smoking history. The current analysis was restricted to 4279 individuals free of cancer who had baseline data on pack-year smoking history and duration of smoking cessation. The current analysis was conducted from January 7, 2022, to May 25, 2022. Exposures Current and prior tobacco use. Main Outcomes and Measures Incident lung cancer during a median (IQR) of 13.3 (7.9-18.8) years of follow-up (range, 0 to 22.6) through December 31, 2011. A Fine-Gray subdistribution hazard model was used to estimate incidence of lung cancer in the presence of competing risk of death. Cox cause-specific hazard regression models were used to estimate hazard ratios (HRs) and 95% CIs for incident lung cancer. Results There were 4279 CHS participants (mean [SD] age, 72.8 [5.6] years; 2450 [57.3%] women; 663 [15.5%] African American, 3585 [83.8%] White, and 31 [0.7%] of other race or ethnicity) included in the current analysis. Among the 861 nonheavy smokers (<20 pack-years), the median (IQR) pack-year smoking history was 7.6 (3.3-13.5) pack-years for the 615 former smokers with 15 or more years of smoking cessation, 10.0 (5.3-14.9) pack-years for the 146 former smokers with less than 15 years of smoking cessation, and 11.4 (7.3-14.4) pack-years for the 100 current smokers. Among the 1445 heavy smokers (20 or more pack-years), the median (IQR) pack-year smoking history was 34.8 (26.3-48.0) pack-years for the 516 former smokers with 15 or more years of smoking cessation, 48.0 (35.0-70.0) pack-years for the 497 former smokers with less than 15 years of smoking cessation, and 48.8 (31.6-57.0) pack-years for the 432 current smokers. Incident lung cancer occurred in 10 of 1973 never smokers (0.5%), 5 of 100 current smokers with less than 20 pack-years of smoking (5.0%), and 26 of 516 former smokers with 20 or more pack-years of smoking with 15 or more years of smoking cessation (5.0%). Compared with never smokers, cause-specific HRs for incident lung cancer in the 2 groups for whom LDCT is not recommended were 10.54 (95% CI, 3.60-30.83) for the current nonheavy smokers and 11.19 (95% CI, 5.40-23.21) for the former smokers with less than 15 years of smoking cessation; age, sex, and race-adjusted HRs were 10.06 (95% CI, 3.41-29.70) for the current nonheavy smokers and 10.22 (4.86-21.50) for the former smokers with less than 15 years of smoking cessation compared with never smokers. Conclusions and Relevance The findings of this cohort study suggest that there is a high risk of lung cancer among smokers for whom LDCT screening is not recommended, suggesting that prediction models are needed to identify high-risk subsets of these smokers for screening.

[1]  P. Bůžková Competing risk of mortality in association studies of non-fatal events , 2021, PloS one.

[2]  C. Morgan,et al.  Income disparity and incident cardiovascular disease in older Americans. , 2021, Progress in cardiovascular diseases.

[3]  M. Cabana,et al.  Screening for Lung Cancer: US Preventive Services Task Force Recommendation Statement. , 2021, JAMA.

[4]  Summer S. Han,et al.  Evaluation of the Benefits and Harms of Lung Cancer Screening With Low-Dose Computed Tomography: Modeling Study for the US Preventive Services Task Force. , 2021, JAMA.

[5]  S. H. Regli,et al.  Validation of a Machine Learning Algorithm to Predict 180-Day Mortality for Outpatients With Cancer. , 2020, JAMA oncology.

[6]  M. Hernán,et al.  Why Test for Proportional Hazards? , 2020, JAMA.

[7]  M. P. Mulder,et al.  Effect of a Machine Learning-Derived Early Warning System for Intraoperative Hypotension vs Standard Care on Depth and Duration of Intraoperative Hypotension During Elective Noncardiac Surgery: The HYPE Randomized Clinical Trial. , 2020, JAMA.

[8]  Harry J de Koning,et al.  Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial. , 2020, The New England journal of medicine.

[9]  P. Bůžková,et al.  Assessing risk factors of non-fatal outcomes amid a competing risk of mortality: the example of hip fracture , 2019, Osteoporosis International.

[10]  Tushar Singh,et al.  Age of tobacco use initiation and association with current use and nicotine dependence among US middle and high school students, 2014–2016 , 2018, Tobacco Control.

[11]  Marianna B. Shershneva,et al.  Typical Time to Treatment of Patients With Lung Cancer in a Multisite, US-Based Study. , 2016, Journal of oncology practice.

[12]  Jason P. Fine,et al.  Statistical Primer for Cardiovascular Research Introduction to the Analysis of Survival Data in the Presence of Competing Risks , 2022 .

[13]  L. Kuller,et al.  Study of Cardiovascular Health Outcomes in the Era of Claims Data: The Cardiovascular Health Study , 2016, Circulation.

[14]  G. Filippatos,et al.  Risk of Heart Failure and Death After Prolonged Smoking CessationCLINICAL PERSPECTIVE , 2015 .

[15]  G. Molenberghs,et al.  Comparison of risks of cardiovascular events in the elderly using standard survival analysis and multiple-events and recurrent-events methods , 2015, BMC Medical Research Methodology.

[16]  William Hazelton,et al.  Benefits and Harms of Computed Tomography Lung Cancer Screening Strategies: A Comparative Modeling Study for the U.S. Preventive Services Task Force , 2014, Annals of Internal Medicine.

[17]  S. J. Henley,et al.  Lung Cancer Incidence Trends Among Men and Women — United States, 2005–2009 , 2014, MMWR. Morbidity and mortality weekly report.

[18]  S. Blair,et al.  Prevention of heart failure in older adults may require higher levels of physical activity than needed for other cardiovascular events. , 2013, International journal of cardiology.

[19]  G. Bakris,et al.  Isolated Diastolic Hypotension and Incident Heart Failure in Older Adults , 2011, Hypertension.

[20]  C. Gatsonis,et al.  Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening , 2012 .

[21]  J. Robbins,et al.  Long‐Term Retention of Older Adults in the Cardiovascular Health Study: Implications for Studies of the Oldest Old , 2010, Journal of the American Geriatrics Society.

[22]  G. Filippatos,et al.  Effects of Right Ventricular Ejection Fraction on Outcomes in Chronic Systolic Heart Failure , 2010, Circulation.

[23]  S. Cole,et al.  Competing risk regression models for epidemiologic data. , 2009, American journal of epidemiology.

[24]  Ali Ahmed,et al.  Effects of Digoxin on Morbidity and Mortality in Diastolic Heart Failure: The Ancillary Digitalis Investigation Group Trial , 2006, Circulation.

[25]  L. Fried,et al.  Exercise intensity and subclinical cardiovascular disease in the elderly. The Cardiovascular Health Study. , 1997, American journal of epidemiology.

[26]  L. Kuller,et al.  Methods of assessing prevalent cardiovascular disease in the Cardiovascular Health Study. , 1995, Annals of epidemiology.

[27]  Chronic disease reports: deaths from lung cancer--United States, 1986. , 1989, MMWR. Morbidity and mortality weekly report.